Prompt upper endoscopy is an appropriate initial management in uninvestigated chinese patients with typical reflux symptoms

American Journal of Gastroenterology

Volumn 105, Issue 9, 2010, Pages 1947-1952

  Peng, Sui ^a   Xiong, Li Shou ^a   Xiao, Ying Lian ^a   Lin, Jin Kun ^a   Wang, An Jiang ^a   Zhang, Ning ^a   Hu, Pin Jin ^a   Chen, Min Hu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; CHINESE; DISEASE SEVERITY; ESOPHAGUS CARCINOMA; FEMALE; FOOD REGURGITATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REFLUX ESOPHAGITIS; RISK FACTOR; STOMACH CARCINOMA; TREATMENT OUTCOME; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; DRINKING BEHAVIOR; ESOPHAGITIS; HELICOBACTER INFECTIONS; MULTIVARIATE ANALYSIS; OBESITY; RISK; SEX DIFFERENCE;

ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; BARRETT ESOPHAGUS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; OVERWEIGHT; PEPTIC ULCER; PROTON PUMP INHIBITORS; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 77956338760     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.121     Document Type: Article

References (23)

1. Vakil N, van Zanten SV, Kahrilas P, et al., Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920
2. Vaezi MF. Refractory GERD acid, nonacid or not GERD? Am J Gastroenterol 2004; 99: 989-990
3. Fock KM, Talley N, Moayyedi P et al. Asia-Paciffic consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008; 23: 8-22
4. Peng S, Cui Y, Xiao YL et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 2009; 41: 1011-1017
5. Dent J, Kahrilas PJ, Vakil N. Clinical trial design in adult reflux disease: a methodological workshop. Aliment Pharmacol Ther 2008; 28: 107-126
6. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92
7. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004; 127: 310-330
8. Wong BC, Wong WM, Wang WH et al. An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese-the best tests for routine clinical use and research purposes. Aliment Pharmacol Ther 2001; 15: 505-511
9. Dent J, Armstrong D, Delaney B et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004; 53 (Suppl 4): iv1-24
10. World Health Organization. Obesity: preventing and managing the global epidemic. WHO Technical Report Series, No.894 World Health Organization: Geneva, Switzerland, 1997
11. Moayyedi P, Axon AT. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 3122-3125
12. Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 1992; 120: 45-173
13. Gastrointestinal Motility Group of Digestive Disease Branch of Chinese Medical Association. Consensus on management of gastroesophageal reflex disease (2007 Xi ' an). Chinese J Digestion 2007; 27: 689-690 (Chinese)
14. Lagergren J, Bergstr ö m R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831
15. Suvakovic Z, Bramble MG, Jones R et al. Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study. Gut 1997; 41: 308-313
16. Bramble MG, Suvakovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000; 46: 464-467
17. Manes G, Mosca S, De Nucci C et al. High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. Dig Liver Dis 2001; 33: 665-670
18. Delaney BC, Wilson S, Roalfe A et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomized controlled trial in primary care. Lancet 2000; 356: 1965-1969
19. Chen WQ. Estimation of cancer incidence and mortality in China in 2004-2005. Zhonghua Zhong Liu Za Zhi 2009; 31: 664-668, Chinese
20. Van Pinxteren B, Numans ME, Lau J et al. Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med 2003; 18: 755-763
21. Johnsson F, Hatlebakk JG, Klintenberg AC et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003; 38: 354-359
22. Fass R, Ofman JJ, Sampliner RE et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients wiTherosive oesophagitis. Aliment Pharmacol Ther 2000; 14: 389-396
23. Talley NJ, Armstrong D, Junghard O et al. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2006; 24: 371-376.